The Headache Center
Ridgeland, Mississippi 39157
We've found
3 trials
at this facility
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)
Chronic Migraine Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)